Prothena Corp plc (42) | License Agreements (5)
Recent Contracts
-
Amendment No. 2 to License, Development, and Commercialization Agreement, entered into on December 11, 2013, among Prothena Biosciences Limited, Prothena Biosciences Inc, F....
(Filed With SEC on November 4, 2021)
-
U.S. License Agreement, dated as of July 30, 2021, as amended on August 12, 2021 and September 8, 2021, by and between Prothena Biosciences Limited and Celgene Switzerland LLC
(Filed With SEC on November 4, 2021)
-
License Agreement, dated as of March 1, 2020, between Prothena Biosciences Limited and F. Hoffmann-La Roche Ltd
(Filed With SEC on May 6, 2020)
-
Understanding Related to License, Development, and Commercialization Agreement, dated as of March 1, 2020, among Prothena Biosciences Limited, Prothena Biosciences Inc, F....
(Filed With SEC on May 6, 2020)
-
Amendment to License, Development, and Commercialization Agreement, entered into on October 1, 2019, among Prothena Biosciences Limited, Prothena Biosciences Inc, F. Hoffman-La...
(Filed With SEC on March 3, 2020)